6 results
10-K
2023 FY
EX-10.12
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
that if the alleged breaching Party disputes in good faith the existence or materiality of a breach specified in a notice provided by the other Party
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
materiality” assessment. This means that in-scope entities will have to assess both financial materiality, which are sustainability matters which generate … , access to finance or cost of capital over the short-, medium- or long-term, and impact materiality, which are the company’s material actual or potential
6-K
EX-1
AUTL
Autolus Therapeutics plc
1 Jul 22
Current report (foreign)
5:15pm
assessment of investment in subsidiaries (Parent Company only)
Materiality
Overall group materiality of £2.25m which represents 2% of adjusted operating … of the parent and group audits
Tailoring the scope
Our assessment of audit risk, our evaluation of materiality and our allocation of performance
6-K
EX-1
AUTL
Autolus Therapeutics plc
30 Jun 21
Annual Report and Accounts
6:05am
accounting for costs arising from contracts due to inaccurate application of accounting principles and completeness of R&D accruals.
Materiality …
Overall group materiality of £2.29m which represents 2% of adjusted operating costs.
An overview of the scope of the parent and group audits
Tailoring
6-K
EX-1
AUTL
Autolus Therapeutics plc
26 May 20
Current report (foreign)
4:31pm
and 100% of Total assets.
Materiality
Overall group materiality of £1.79m which represents 2% of annualised operating costs.
Key audit matters … audit
Tailoring the scope
Our assessment of audit risk, our evaluation of materiality and our allocation of performance materiality determine our audit
6-K
EX-1
dhxvheoo77x3b wigsh
15 Mar 19
Annual Report and Accounts
5:26pm
- Prev
- 1
- Next